These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8513798)

  • 1. The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties.
    Goffin V; Struman I; Goormaghtigh E; Martial JA
    Eur J Biochem; 1993 Jun; 214(2):483-90. PubMed ID: 8513798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lactogen receptor-binding site 1 of human prolactin.
    Kinet S; Goffin V; Mainfroid V; Martial JA
    J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity.
    Goffin V; Norman M; Martial JA
    Mol Endocrinol; 1992 Sep; 6(9):1381-92. PubMed ID: 1435787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a model to understand prolactin and growth hormone specificities.
    Goffin V; Martial JA; Summers NL
    Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor.
    Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T
    Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures.
    Luck DN; Huyer M; Gout PW; Beer CT; Smith M
    Mol Endocrinol; 1991 Dec; 5(12):1880-6. PubMed ID: 1791836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC; Brooks CL
    Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
    Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
    Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling of rabbit prolactin hormone complexed with its receptor.
    Halaby D; Thoreau E; Djiane J; Mornon JP
    Proteins; 1997 Mar; 27(3):459-68. PubMed ID: 9094747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the receptor binding and Nb2 proliferation activities of rat prolactin by site-directed mutagenesis.
    Kato Y; Tomizawa K; Kato T
    Zoolog Sci; 1997 Feb; 14(1):147-52. PubMed ID: 9200987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a second receptor binding site on human prolactin.
    Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA
    J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modification of recombinant bovine placental lactogen by site-directed mutagenesis at its C terminus.
    Vashdi-Elberg D; Staten NR; Sakal E; McKinnie RE; Djiane J; Krivi GG; Gertler A
    J Biol Chem; 1996 Mar; 271(10):5558-64. PubMed ID: 8621415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acids in the amino terminal region of the rat prolactin contribute to PRL-receptor binding and NB2 cell proliferation activity.
    Maruyama O; Kato T; Wakabayashi K; Kato Y
    Biochem Biophys Res Commun; 1994 Nov; 205(1):312-9. PubMed ID: 7999042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.
    Gertler A
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):69-80. PubMed ID: 10887521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a motif associated with the lactogenic actions of human growth hormone.
    Peterson FC; Brooks CL
    J Biol Chem; 1997 Aug; 272(34):21444-8. PubMed ID: 9261160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of arginine residues in ovine prolactin by 1,2-cyclohexanedione. Effect on binding capacity to lactogenic receptors.
    Cymes GD; Atlasovich FM; Caridad JJ; Iglesias MM; Wolfenstein-Todel C
    Int J Pept Protein Res; 1994 Jul; 44(1):31-5. PubMed ID: 7960402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of lactogenic receptors from rat liver and Nb2 rat lymphoma cells by using cross-linking techniques.
    Webb CF; Wallis M
    Biochem J; 1988 Feb; 250(1):215-9. PubMed ID: 3355513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
    Jomain JB; Tallet E; Broutin I; Hoos S; van Agthoven J; Ducruix A; Kelly PA; Kragelund BB; England P; Goffin V
    J Biol Chem; 2007 Nov; 282(45):33118-31. PubMed ID: 17785459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of prolactin receptor antagonists with reduced pH-dependence of receptor binding.
    Hansen MJ; Olsen JG; Bernichtein S; O'Shea C; Sigurskjold BW; Goffin V; Kragelund BB
    J Mol Recognit; 2011; 24(4):533-47. PubMed ID: 20842635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.